<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE298nnn/GSE298418/</Other></files><type>primary</type></body><statusCodeValue>200</statusCodeValue><statusCode>OK</statusCode></file_versions><scores/><additional><omics_type>Genomics</omics_type><species>Mus musculus</species><gds_type>Genome binding/occupancy profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298418</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>MeCP2 stabilizes the glucocorticoid system in active chromatin regions [CUT&amp;Tag]</name><description>Methyl-CpG-binding protein 2 (MeCP2), a key epigenetic factor regulating gene expression via DNA/chromatin interactions, causes Rett syndrome when dysfunctional. However, its regulatory mechanisms at the pan-tissue and multi-omics levels remain poorly understood. Here, we constructed comprehensive pan-tissue transcriptional profiles and chromatin accessibility profiles from wild-type and Mecp2-knockout mice. Integrative analyses revealed that glucocorticoid (GC)-induced genes (GIGs) exhibited global hyperactivation following Mecp2 knockout, highlighting a crucial role for MeCP2 in maintaining GC signaling homeostasis. Through innovative single-cell multi-omics profiling of the nervous system, we found that GIG dysregulation primarily disrupts neural homeostasis via non-neuronal cells. Mechanistically, we uncovered a dual regulatory mode of MeCP2: (1) competitively limiting NR3C1 occupancy at GIG cis-regulatory elements in active chromatin regions, and (2) specifically disrupting NR3C1-NCOA1 coactivator interactions. Importantly, pharmacologically suppressing aberrant GC system activation ameliorated pathological phenotypes and significantly prolonged survival in Mecp2-knockout mice. Our study demonstrates the critical pathological role of hyperactivated GC signaling in the multisystem disturbances of Mecp2-knockout mice and suggests potential therapeutic targets for Rett syndrome.</description><dates><publication>2026/07/31</publication></dates><accession>GSE298418</accession><cross_references><GSM>GSM9014029</GSM><GSM>GSM9014028</GSM><GSM>GSM9014027</GSM><GSM>GSM9014026</GSM><GSM>GSM9014025</GSM><GSM>GSM9014024</GSM><GSM>GSM9014023</GSM><GSM>GSM9014022</GSM><GSM>GSM9014021</GSM><GSM>GSM9014020</GSM><GSM>GSM9014019</GSM><GSM>GSM9014018</GSM><GSM>GSM9014017</GSM><GSM>GSM9014016</GSM><GSM>GSM9014015</GSM><GSM>GSM9014014</GSM><GSM>GSM9014013</GSM><GSM>GSM9014012</GSM><GSM>GSM9014011</GSM><GSM>GSM9014010</GSM><GSM>GSM9013999</GSM><GSM>GSM9014009</GSM><GSM>GSM9013998</GSM><GSM>GSM9014008</GSM><GSM>GSM9013997</GSM><GSM>GSM9014007</GSM><GSM>GSM9013996</GSM><GSM>GSM9014006</GSM><GSM>GSM9013995</GSM><GSM>GSM9014005</GSM><GSM>GSM9013994</GSM><GSM>GSM9014004</GSM><GSM>GSM9013993</GSM><GSM>GSM9013992</GSM><GSM>GSM9014003</GSM><GSM>GSM9014002</GSM><GSM>GSM9013991</GSM><GSM>GSM9014001</GSM><GSM>GSM9013990</GSM><GSM>GSM9014044</GSM><GSM>GSM9014000</GSM><GSM>GSM9014043</GSM><GSM>GSM9014042</GSM><GSM>GSM9014041</GSM><GSM>GSM9014040</GSM><GSM>GSM9931283</GSM><GSM>GSM9931284</GSM><GSM>GSM9931281</GSM><GSM>GSM9931282</GSM><GSM>GSM9013989</GSM><GSM>GSM9013988</GSM><GSM>GSM9013987</GSM><GSM>GSM9013986</GSM><GSM>GSM9014039</GSM><GSM>GSM9014038</GSM><GSM>GSM9014037</GSM><GSM>GSM9014036</GSM><GSM>GSM9014035</GSM><GSM>GSM9014034</GSM><GSM>GSM9014033</GSM><GSM>GSM9014032</GSM><GSM>GSM9014031</GSM><GSM>GSM9014030</GSM><GPL>28330</GPL><GPL>34290</GPL><GSE>298418</GSE><taxon>Mus musculus</taxon></cross_references></HashMap>